These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 18623923)
1. Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro. Chu EH; Stjernswärd J; Clifford P; Klein G J Natl Cancer Inst; 1967 Oct; 39(4):595-617. PubMed ID: 18623923 [TBL] [Abstract][Full Text] [Related]
2. In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia. Khare AG; Advani SH; Gangal SG Br J Cancer; 1981 Jan; 43(1):13-8. PubMed ID: 6450603 [TBL] [Abstract][Full Text] [Related]
3. Reactivity of serum from rous-sarcoma-bearing chickens with autochthonous and with allogeneic tumor cells: preferential autochthonous recognition. Wainberg MA; Markson Y; Doljanski F; Weiss DW Int J Cancer; 1975 Jun; 15(6):985-94. PubMed ID: 168159 [TBL] [Abstract][Full Text] [Related]
4. Neuraminidase alteration of human lymphocyte reactivity to mitogens, antigens and allogenic lymphocytes. Pauly JL; Germain MJ; Han T J Med; 1978; 9(3):223-36. PubMed ID: 283169 [TBL] [Abstract][Full Text] [Related]
5. The relationship of lytic effects against autologous and allogeneic PHA blasts induced in human mixed lymphocyte cultures. Porzsolt F; Heimpel H Immunol Lett; 1984; 8(1):33-8. PubMed ID: 6235182 [TBL] [Abstract][Full Text] [Related]
6. Lymphocyte reactivity to mitogens in American visceral leishmaniasis. Carvalho EM; Bacellar OA Braz J Med Biol Res; 1983 Apr; 16(1):35-41. PubMed ID: 6640172 [TBL] [Abstract][Full Text] [Related]
7. Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor. Vánky F; Gorsky T; Gorsky Y; Masucci MG; Klein E J Exp Med; 1982 Jan; 155(1):83-95. PubMed ID: 6459402 [TBL] [Abstract][Full Text] [Related]
8. Lymphocyte blastogenic responses to allogeneic leukocytes and autochthonous tumor cells in colorectal carcinoma. Jubert AV; Talbott TM; Mazier WP; MacKeigan JM; Campos MM; Muldoon JP; Benjamin HE; Ferguson JA; Bowman HE J Surg Oncol; 1977; 9(2):171-8. PubMed ID: 140957 [TBL] [Abstract][Full Text] [Related]
9. Proliferation of human lymphocytes by mitogen stimulated cells. Jaroszewski J; Kurpisz M; Brelińska-Peczalska R; Lastowska M Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):283-8. PubMed ID: 749780 [TBL] [Abstract][Full Text] [Related]
10. Mycoplasma bovis suppression of bovine lymphocyte response to phytohemagglutinin. Thomas CB; Mettler J; Sharp P; Jensen-Kostenbader J; Schultz RD Vet Immunol Immunopathol; 1990 Oct; 26(2):143-55. PubMed ID: 2260280 [TBL] [Abstract][Full Text] [Related]
12. Immunologic study on nasopharyngeal carcinoma patients: correlation of in vivo and in vitro reactivity to phytohemagglutinin. Hsu MM; Lo P Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Feb; 16(1):20-32. PubMed ID: 6851721 [TBL] [Abstract][Full Text] [Related]
13. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2. Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498 [TBL] [Abstract][Full Text] [Related]
14. T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation. Kurnick JT; Warrens AR; Moscicki RA; Leary CP Clin Immunol Immunopathol; 1983 Jun; 27(3):444-51. PubMed ID: 6223760 [TBL] [Abstract][Full Text] [Related]
15. Optimization of culture conditions for activation and large-scale expansion of human T lymphocytes for bispecific antibody-directed cellular immunotherapy. Lamers CH; van de Griend RJ; Braakman E; Ronteltap CP; Bénard J; Stoter G; Gratama JW; Bolhuis RL Int J Cancer; 1992 Jul; 51(6):973-9. PubMed ID: 1386349 [TBL] [Abstract][Full Text] [Related]
16. Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients. Bukowski RM; Barna B; Deodhar SD; Hewlett JS Cancer; 1976 Nov; 38(5):1962-7. PubMed ID: 991109 [TBL] [Abstract][Full Text] [Related]
17. Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes. Vánky F; Klein E Int J Cancer; 1982 May; 29(5):547-53. PubMed ID: 6178704 [TBL] [Abstract][Full Text] [Related]
18. Serologic analysis of human tumor antigens. II. Reactivity of sera from eleven osetogenic sarcoma patients against autologous and allogeneic tumor cells. Rosenberg SA; Tondreau SC; Shoffner PC; Hyatt C; Brown JM; Thorpe W; Sindelar W Surgery; 1979 Aug; 86(2):258-65. PubMed ID: 288177 [TBL] [Abstract][Full Text] [Related]
19. Suppression of mitogen-induced lymphocyte transformation in cigarette smokers. Petersen BH; Steimel LF; Callaghan JT Clin Immunol Immunopathol; 1983 Apr; 27(1):135-40. PubMed ID: 6872351 [TBL] [Abstract][Full Text] [Related]
20. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization. de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]